Related Experiment Video
Updated: Feb 8, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
The complex molecular genetics of familial hypercholesterolaemia
Amanda J Berberich1, Robert A Hegele2
1Departments of Medicine and Biochemistry, and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Insights
Familial hypercholesterolaemia (FH) is a common genetic disorder causing early cardiovascular disease, yet it remains underdiagnosed and undertreated. Understanding its genetic complexity is key to improving diagnosis and patient outcomes.
Area of Science:
- Cardiovascular Genetics
- Metabolic Disorders
- Clinical Lipidology
Background:
- Familial hypercholesterolaemia (FH) is the most prevalent genetic disorder linked to premature cardiovascular disease.
- A significant proportion of FH patients remain undiagnosed or receive suboptimal treatment.
- Recent advancements in molecular technologies are refining our understanding of FH prevalence and its complex genetic underpinnings.
Purpose of the Study:
- To highlight the diagnostic challenges and complexities of Familial hypercholesterolaemia.
- To emphasize the evolving understanding of FH due to genetic research.
- To underscore the importance of elevated LDL cholesterol as a diagnostic and therapeutic trigger.
Main Methods:
- Review of current understanding of FH pathophysiology and genetics.
- Analysis of diagnostic criteria and the role of genetic testing.
- Discussion of clinical features and their diagnostic implications.
Main Results:
- FH is a spectrum of disorders, not limited to the classic phenotype.
- Genetic testing can be complex and not always definitive for diagnosis.
- Elevated LDL cholesterol is the primary indicator, even without classic signs.
Conclusions:
- FH diagnosis requires a comprehensive approach, integrating clinical, family, and genetic data.
- Elevated LDL cholesterol levels are paramount for initiating management, regardless of other indicators.
- Early intervention with lifestyle changes and lipid-lowering therapy is crucial for cardiovascular disease prevention in FH.
Abstract:
Familial hypercholesterolaemia is the most commonly encountered genetic condition that predisposes individuals to premature cardiovascular disease. Nevertheless, most patients are undiagnosed, and treatment is often suboptimal even when the diagnosis seems certain. Advances in molecular technologies are reshaping our understanding of this condition, including revision upwards of the population prevalence. Furthermore, the underlying pathophysiological complexity has been exposed by the range of causative genetic loci, breadth of types and classes of rare disease-causing variants, and polygenic basis of the phenotype in many patients. Genetic testing is not always helpful or definitive. Familial hypercholesterolaemia can be envisioned as a group of related disorders, of which the classic 'textbook' phenotype is a subset. Features such as clinical stigmata, family history of dyslipidaemia or cardiovascular disease, and presence of a rare pathogenic variant all increase diagnostic certainty. However, even in the absence of these elements, the essential feature remains an elevated level of plasma LDL cholesterol, which alone should prompt a dialogue between the care provider and the patient on lifestyle modification and lipid-lowering therapy as the foundation of a long-term strategy to prevent or delay the onset of cardiovascular disease.
Related Concept Videos
Protein Families
Protein Families
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
Family Therapy
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
Molecular Chaperones and Protein Folding
The...

